Sysmex

Skip Navigation

SearchMenu

R&D Vision and Directions

Personalized Medicine

Aiming to Select the Best Treatment Methods for Individual Patients

Until now, medical treatment has been disease-based, and a uniform treatment is selected for a given disease. For that reason, diagnostic testing has focused on identifying disease as precisely as possible. However, disease states differ by person, so it is understood that the same treatment method may not be appropriate even for people with the same disease. Nevertheless, selecting the treatment method that is optimal for an individual patient has been extremely difficult.
In recent years, advances in genetic analysis technology have improved precision in identifying diseases and help in evaluating recurrence risk and prognosis.
Where treatment is concerned, the efficacy and side effects of drugs can be predicted when selecting medication, making it possible to select the most optimal treatment for each and every patient. This both reduces the physical burden on the patient and helps control medical costs.

Concept of realizing personalized medicine through testing

Personalized Medicine Aiming to Select the Best Treatment Methods for Individual Patients

Sysmex’s Initiatives

In the past, testing involving specimen sampling (biopsy) was used for direct analysis of the affected tissue, which placed a major burden on the patient. To reduce the burden on patients, Sysmex is promoting R&D activities toward the establishment of new testing technologies for analyzing disease-derived cells, genes, proteins and other elements present in blood and bodily fluids (liquid biopsy).
From testing by sampling specimens (biopsy) to analyzing blood (liquid biopsy)

Principal disease-derived elements present in blood and bodily fluids

Principal disease-derived elements present in blood and bodily fluids
Back to "R&D Vision and Directions"